Search Result "Mabs-PCSK9"
PCSK9 Inhibition-Based Therapeutic Approaches: An ImmunotherapyPerspective
Journal: Current Medicinal Chemistry
Volume: 29 Issue: 6 Year: 2022 Page: 980-999
Author(s): Amirhossein Sahebkar,Suowen Xu,Matteo Pirro,Amir Abbas Momtazi-Borojeni
Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Inhibitors in the Treatment of Hypercholesterolemia and other Pathologies
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 1 Year: 2013 Page: 3161-3172
Author(s): Nabil G. Seidah
PCSK9 Inhibition with Evolocumab Reaching Physiologic LDL-C Levels for Reducing Atherosclerotic Burden and Cardiovascular Disease-The Full Landscape
Ebook: Recent Advances in Alzheimer Research
Volume: 4 Year: 2019
Author(s): Enrique C. Morales-Villegas,Kausik K. Ray
Doi: 10.2174/97816810839951180401
Pharmacology of PCSK9 Inhibitors: Current Status and Future Perspectives
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 31 Year: 2018 Page: 3622-3633
Author(s): Aikaterini N. Tsouka,Constantinos C. Tellis,Alexandros D. Tselepis
Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9): Impact of PCSK9 on Major Adverse Cardiac and Cerebrovascular Events
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 14 Issue: 2 Year: 2016 Page: 94-100
Author(s): Muharrem Akin,Thomas Skripuletz,L. Christian Napp,Dominik Berliner,Ibrahim Akin,Arash Haghikia,Elvan Akin,Johann Bauersachs
PCSK9 Inhibition in Atherosclerotic Cardiovascular Disease
Journal: Current Pharmaceutical Design
Volume: 29 Issue: 23 Year: 2023 Page: 1802-1824
Author(s):
Structure and Function of Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) in Hyperlipidemia and Atherosclerosis
Journal: Current Drug Targets
Volume: 20 Issue: 10 Year: 2019 Page: 1029-1040
Author(s): Xinjie Lu
PCSK9 Inhibitors and Cardiovascular Disease: Impact on Cardiovascular Outcomes
Journal: Current Drug Discovery Technologies
Volume: 17 Issue: 2 Year: 2020 Page: 138-146
Author(s): Paraskevi Farmaki,Christos Damaskos,Nikolaos Garmpis,Anna Garmpi,Spyridon Savvanis,Evangelos Diamantis
PCSK9 Biomarker and Key Modulator for Cardiovascular Disorders:Heralding a New Therapeutic Era and Their Future Perspectives
Journal: Current Molecular Pharmacology
Volume: 16 Issue: 8 Year: 2023 Page: 832-854
Author(s):
A Review of PCSK9 Inhibitors and their Effects on Cardiovascular Diseases
Journal: Current Topics in Medicinal Chemistry
Volume: 19 Issue: 20 Year: 2019 Page: 1790-1817
Author(s): Bo Chen,Xin Shi,Yanping Cui,Aiping Hou,Pengjun Zhao